Understanding how cells create autophagosomes to manage stress and toxins
Mechanisms of autophagosome biogenesis
This study looks at how our cells create special structures called autophagosomes to help get rid of harmful stuff when they're under stress, like from aging parts or infections, and it aims to understand the processes involved so we can better support cell health, especially during illness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11063249 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which cells form autophagosomes, specialized structures that encapsulate and eliminate harmful components within the cell. It focuses on how cells respond to stress from aging organelles and pathogen invasion by constructing these organelles to sequester toxins. The study aims to uncover the machinery involved in lipid transport necessary for autophagosome formation, which is crucial for maintaining cellular health. By exploring these processes, the research seeks to provide insights into how cells manage internal challenges, especially during disease states.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve cellular stress, such as cancer patients or those with neurodegenerative diseases.
Not a fit: Patients with acute infections or those not experiencing cellular stress-related conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases related to cellular stress and dysfunction, such as cancer and neurodegenerative disorders.
How similar studies have performed: Other research has shown success in understanding cellular mechanisms related to autophagy, indicating that this area of study has potential for significant breakthroughs.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Melia, Thomas James — Yale University
- Study coordinator: Melia, Thomas James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.